PMID- 33096882 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20201030 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 9 IP - 10 DP - 2020 Oct 21 TI - The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians. LID - 10.3390/jcm9103379 [doi] LID - 3379 AB - Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening thrombotic microangiopathy caused by severe ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin motifs 13) deficiency, recurring in 30-50% of patients. The common human leukocyte antigen (HLA) variant rs6903608 was found to be associated with prevalent iTTP, but whether this variant is associated with disease relapse is unknown. To estimate the impact of rs6903608 on iTTP onset and relapse, we performed a case-control and cohort study in 161 Italian patients with a first iTTP episode between 2002 and 2018, and in 456 Italian controls. Variation in rs6903608 was strongly associated with iTTP onset (homozygotes odds ratio (OR) 4.68 (95% confidence interval (CI) 2.67 to 8.23); heterozygotes OR 1.64 (95%CI 0.95 to 2.83)), which occurred over three years earlier for each extra risk allele (beta -3.34, 95%CI -6.69 to 0.02). Of 153 survivors (median follow-up 4.9 years (95%CI 3.7 to 6.1)), 44 (29%) relapsed. The risk allele homozygotes had a 46% (95%CI 36 to 57%) absolute risk of relapse by year 6, which was significantly higher than both heterozygotes (22% (95%CI 16 to 29%)) and reference allele homozygotes (30% (95%CI 23 to 39%)). In conclusion, HLA variant rs6903608 is a risk factor for both iTTP onset and relapse. This newly identified biomarker may help with recognizing patients at high risk of relapse, who would benefit from close monitoring or intensified immunosuppressive therapy. FAU - Mancini, Ilaria AU - Mancini I AUID- ORCID: 0000-0002-5059-5212 AD - Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, and Fondazione Luigi Villa, 20122 Milan, Italy. FAU - Giacomini, Elisa AU - Giacomini E AD - Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, and Fondazione Luigi Villa, 20122 Milan, Italy. FAU - Pontiggia, Silvia AU - Pontiggia S AD - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy. FAU - Artoni, Andrea AU - Artoni A AD - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy. FAU - Ferrari, Barbara AU - Ferrari B AD - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy. FAU - Pappalardo, Emanuela AU - Pappalardo E AD - Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, and Fondazione Luigi Villa, 20122 Milan, Italy. FAU - Gualtierotti, Roberta AU - Gualtierotti R AUID- ORCID: 0000-0001-6465-7624 AD - Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, and Fondazione Luigi Villa, 20122 Milan, Italy. AD - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy. FAU - Trisolini, Silvia Maria AU - Trisolini SM AD - Hematology, Department of Translational and Precision Medicine, "Sapienza" University of Rome, 00161 Rome, Italy. FAU - Capria, Saveria AU - Capria S AD - Hematology, Department of Translational and Precision Medicine, "Sapienza" University of Rome, 00161 Rome, Italy. FAU - Facchini, Luca AU - Facchini L AD - Hematology Unit, Azienda Unita Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy. FAU - Codeluppi, Katia AU - Codeluppi K AD - Hematology Unit, Azienda Unita Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy. FAU - Rinaldi, Erminia AU - Rinaldi E AD - Hematology Unit, A. Perrino Hospital, 72100 Brindisi, Italy. FAU - Pastore, Domenico AU - Pastore D AD - Hematology Unit, A. Perrino Hospital, 72100 Brindisi, Italy. FAU - Campus, Simona AU - Campus S AD - Pediatric Unit, Ospedale Microcitemico, 09121 Cagliari, Italy. FAU - Caria, Cinzia AU - Caria C AD - Internal Medicine Unit, S.S. Trinita Hospital, 09121 Cagliari, Italy. FAU - Caddori, Aldo AU - Caddori A AD - Internal Medicine Unit, S.S. Trinita Hospital, 09121 Cagliari, Italy. FAU - Nicolosi, Daniela AU - Nicolosi D AD - Hematology Division, Department of Clinical and Molecular Biomedicine, University of Catania, 95123 Catania, Italy. FAU - Giuffrida, Gaetano AU - Giuffrida G AD - Hematology Division, Department of Clinical and Molecular Biomedicine, University of Catania, 95123 Catania, Italy. FAU - Agostini, Vanessa AU - Agostini V AD - U.O. Medicina Trasfusionale, IRCCS-Ospedale Policlinico San Martino, 16132 Genova, Italy. FAU - Roncarati, Umberto AU - Roncarati U AD - U.O. Immunoematologia e Medicina Trasfusionale/Officina Trasfusionale, Cesena e Forli, 47521 Cesena, Italy. FAU - Mannarella, Clara AU - Mannarella C AD - Hematology Unit, Madonna delle Grazie Hospital, 75100 Matera, Italy. FAU - Fragasso, Alberto AU - Fragasso A AD - Hematology Unit, Madonna delle Grazie Hospital, 75100 Matera, Italy. FAU - Podda, Gian Marco AU - Podda GM AUID- ORCID: 0000-0002-1791-8905 AD - U.O. Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Universita degli Studi di Milano, 20142 Milan, Italy. FAU - Birocchi, Simone AU - Birocchi S AD - U.O. Medicina III, ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Universita degli Studi di Milano, 20142 Milan, Italy. FAU - Cerbone, Anna Maria AU - Cerbone AM AD - Department of Clinical Medicine and Surgery, AOU Federico II, 80131 Naples, Italy. FAU - Tufano, Antonella AU - Tufano A AD - Department of Clinical Medicine and Surgery, AOU Federico II, 80131 Naples, Italy. FAU - Menna, Giuseppe AU - Menna G AD - Department of Oncology, AORN Santobono-Pausilipon, 80122 Naples, Italy. FAU - Pizzuti, Michele AU - Pizzuti M AD - Hematology Unit, AO San Carlo, 85100 Potenza, Italy. FAU - Ronchi, Michela AU - Ronchi M AD - Internal Medicine Unit, Department of Medicine, Lugo Hospital, Lugo, 48022 Ravenna, Italy. FAU - De Fanti, Alessandro AU - De Fanti A AD - Departmental Simple Unit of Pediatric Rheumatology, AUSL-IRCSS Reggio Emilia, 42123 Reggio Emilia, Italy. FAU - Amarri, Sergio AU - Amarri S AD - Paediatrics Unit, AUSL-IRCSS Reggio Emilia, 42123 Reggio Emilia, Italy. FAU - Defina, Marzia AU - Defina M AD - Department of Medical, Surgery and Neuroscience, Hematology Unit, Azienda Ospedaliera Universitaria Senese, Universita degli Studi di Siena, 53100 Siena, Italy. FAU - Bocchia, Monica AU - Bocchia M AUID- ORCID: 0000-0003-3538-3913 AD - Department of Medical, Surgery and Neuroscience, Hematology Unit, Azienda Ospedaliera Universitaria Senese, Universita degli Studi di Siena, 53100 Siena, Italy. FAU - Ceru, Silvia AU - Ceru S AD - Hematology Unit, Santa Chiara Hospital, 38122 Trento, Italy. FAU - Gattillo, Salvatore AU - Gattillo S AD - Immuno-Hematology and Transfusion Medicine Unit, San Raffaele Hospital, 20132 Milan, Italy. FAU - Rosendaal, Frits R AU - Rosendaal FR AD - Department of Clinical Epidemiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. FAU - Peyvandi, Flora AU - Peyvandi F AD - Department of Pathophysiology and Transplantation, Universita degli Studi di Milano, and Fondazione Luigi Villa, 20122 Milan, Italy. AD - Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, 20122 Milan, Italy. LA - eng GR - Bando Ricerca Corrente/Ministero della Salute/ PT - Journal Article DEP - 20201021 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC7589625 OTO - NOTNLM OT - ADAMTS13 OT - HLA OT - autoimmune disease OT - genotyping OT - relapse OT - risk factor OT - thrombotic thrombocytopenic purpura COIS- I.M. received honoraria for participating as a speaker at educational meetings organized by Instrumentation Laboratory and Sanofi-Genzyme, outside the submitted work. B.F. received honoraria for participating as a speaker at educational meetings organized by Sanofi-Genzyme. R.G. reports personal fees from Biomarin and Takeda, outside the submitted work. F.P. is a scientific advisory member of Bioverativ, Roche, Sanofi-Genzyme, Sobi, outside the submitted work. V.A. received honoraria for participating as a speaker at educational meetings organized by CSL Behring and is a member of the Sanofi-Genzyme and Werfen-IL scientific advisory boards, outside the submitted work. U.R. is a member of the Sanofi-Genzyme scientific advisory board, outside the submitted work. M.B. received honoraria for participating as a speaker at educational meetings organized by Incyte and Janssen, outside the submitted work. The other authors do not have any conflict of interests to disclose. EDAT- 2020/10/25 06:00 MHDA- 2020/10/25 06:01 PMCR- 2020/10/21 CRDT- 2020/10/24 01:01 PHST- 2020/09/07 00:00 [received] PHST- 2020/10/11 00:00 [revised] PHST- 2020/10/15 00:00 [accepted] PHST- 2020/10/24 01:01 [entrez] PHST- 2020/10/25 06:00 [pubmed] PHST- 2020/10/25 06:01 [medline] PHST- 2020/10/21 00:00 [pmc-release] AID - jcm9103379 [pii] AID - jcm-09-03379 [pii] AID - 10.3390/jcm9103379 [doi] PST - epublish SO - J Clin Med. 2020 Oct 21;9(10):3379. doi: 10.3390/jcm9103379.